搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
英为财情
25 天
100%无广告体验
Curis的研究聚焦于IRAK4蛋白,该蛋白在癌症发展中扮演重要角色,而emavusertib旨在抑制这种蛋白。emavusertib作为PCNSL首个上市治疗方案的潜力,可能为患有这种影响脑部和脊髓的癌症的患者带来希望。 公司的研讨会还阐明了IRAK4抑制在癌症治疗中的更广泛意义 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
NK troops in RU confirmed
Linked to E. coli outbreak
To appear on Rogan podcast
Gun assault trial delayed
To headline 2 Harris rallies
FDA approves RSV vaccine
Bird flu infects 4 in WA
Veteran film producer dies
Ordered to hand over assets
To close 150 locations
Arlington visit records order
Trespassing charge upheld
Kristy now Category 2
FAA finalizes safety rules
DOJ alleges racial bias
2 US troops injured in raid
Hospitals' IV fluid shortage
Giant ‘ghost’ fish spotted
US semiconductor tax credit
MO court upholds release
Dodgers legend dies
GA election rules appeal
2025 Medicare changes
Same-day pharmacy delivery
Brain stimulation study
Funds corruption guilty plea
Lake Erie toxic algae study
First father-son duo in NBA
US fines American Airlines
反馈